NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Clinical trials for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) explained in plain language.
Never miss a new study
Get alerted when new NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR) trials appear
Sign up with your email to follow new studies for NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ancient herb put to the test in fight against Diabetes-Related vision loss
Disease control Not yet recruitingThis study aims to see if a ginkgo biloba extract can help control diabetic retinopathy, a common eye complication of diabetes that can lead to vision loss. It will involve 200 adults with long-term diabetes, comparing the extract against standard care over two years. The main go…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Phase: PHASE2 • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New eye drop trial aims to slow diabetic eye damage
Disease control Not yet recruitingThis very early study will test NPDR-01 eye drops in 10 people with non-proliferative diabetic retinopathy, a common diabetes-related eye condition. The goal is to see if the drops can reduce tiny, leaky blood vessels in the retina (microaneurysms) and slow the disease's progress…
Matched conditions: NON-PROLIFERATIVE DIABETIC RETINOPATHY (NPDR)
Phase: EARLY_PHASE1 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC